Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Publication Title,Pubmed Url,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId,Dataset View_id
PublicationView,CA256054,10.1021/acsomega.3c00705,ACS Omega,37214705,Chemical Activation and Mechanical Sensitization of Piezo1 Enhance TRAIL-Mediated Apoptosis in Glioblastoma Cells,https://pubmed.ncbi.nlm.nih.gov/37214705,2023,,"Samantha V Knoblauch, Shanay H Desai, Jenna A Dombroski, Nicole S Sarna, Jacob M Hope, Michael R King","Glioblastoma multiforme (GBM), the most common and aggressive type of primary brain tumor, has a mean survival of less than 15 months after standard treatment. Treatment with the current standard of care, temozolomide (TMZ), may be ineffective if damaged tumor cells undergo DNA repair or acquire mutations that inactivate transcription factor p53. Tumor necrosis factor-related apoptosis-inducing li(Read more on Pubmed)","Apoptosis Assay, Flow Cytometry",Glioblastoma,Brain ,Not Applicable,Open Access,37214705,93bdfd34-cc82-474c-bfea-5f25cb33b416,syn52566241,37214705
